NewsBytes Stage
    Hindi
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi
    NewsBytes Stage
    India
    Business
    World
    Politics
    Sports
    Technology
    Entertainment
    Auto
    Lifestyle
    Career
    Visual Stories
    Find Cricket Statistics

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
    Home / News / World News / China: PCR test purchases increased before COVID-19 was first confirmed
    Next Article
    China: PCR test purchases increased before COVID-19 was first confirmed
    China informed international authorities about a novel coronavirus, later known as SARS-CoV-2, on January 7, 2020.

    China: PCR test purchases increased before COVID-19 was first confirmed

    By Pratyush Deep Kotoky
    Oct 05, 2021
    07:35 pm

    What's the story

    A cyber security firm suggested that authorities in China alerted global agencies about COVID-19 much later than the emergence of the disease.

    The Australian-US firm, Internet 2.0, reached the conclusions after analyzing purchases of polymerase chain reaction (PCR) testing equipment in the Hubei province, which is home to Wuhan, where the outbreak was first reported in late 2019.

    Details

    PCR test purchases rose in second half of 2019: Study

    The study by Internet 2.0 analyzed purchases of PCR testing equipment in Hubei province.

    It found that the purchases of PCR testing equipment shot upward in 2019, with most of the increase coming in the second half of the year.

    Notably, PCR tests allow scientists to amplify DNA samples or other genetic material to test for infectious diseases.

    Background

    China alerted about new coronavirus in January 2020

    The study suggests that COVID-19 emerged in China in the second half of 2019.

    On December 31, 2019, the World Health Organization reported that its China Country Office was informed that cases of pneumonia from an unknown cause had been detected in the city.

    However, Chinese authorities revealed the identification of a new type of coronavirus—now known as SARS-CoV-2—on January 7, 2020.

    China

    China dismisses findings; calls it dubious

    However, China's Foreign Ministry disputed the findings, saying the report falls into the same category as other "dubious claims" about the origins of the coronavirus.

    It said the findings are similar to the "so-called paper" that analyzed traffic volumes near several hospitals in Wuhan and searched for the keywords "cough" and "diarrhea" before concluding that the outbreak began in Wuhan in August 2019.

    Quote

    Virus traceability a serious scientific issue: China

    Dismissing the findings, the Chinese Foreign Ministry said, "Virus traceability is a serious scientific issue that should be addressed by scientists." It also added, "China's anti-epidemic campaign is open to the world...the situation is clear...the facts are clear....and stand the test of time and history."

    Internet 2.0

    'China's reluctance to provide evidence pushed us for third-party data'

    David Robinson, Internet 2.0's co-CEO, said the timing and the agencies behind the purchases support the idea that officials in Hubei province were investigating a new human disease throughout the second half of 2019.

    However, Internet 2.0 maintained that the data doesn't support any COVID-19 origin conclusions.

    It said China's reluctance to provide conclusive evidence pushed them to rely on third-party data points.

    Methodology

    What was the methodology of their study?

    Robinson said Internet 2.0's report is based on purchasing data publicly available on Chinese government websites.

    It collected 1,716 procurement contracts from 2007 to the end of 2019 and then spent months checking and analyzing the data.

    While PCR-related purchases were relatively flat or went up or down slightly in most areas, the Hubei province witnessed a massive jump in purchases in 2019.

    Information

    PCR purchases nearly doubled in Hubei in 2019

    Internet 2.0 found that the Hubei province witnessed an increase in spending on PCR equipment since 2014. But the jump was particularly big in 2019, at 67.36 million yuan from 36.7 million yuan the year before.

    PCR purchase

    Robinson highlighted three 'out of trend' PCR purchases in Hubei

    Robinson highlighted three particular PCR purchases in Hubei that he described as "out of trend."

    These include purchases made by China's People's Liberation Army Airborne Hospital in May 2019, Wuhan Hongshan District Center for Disease Control and Prevention in September 2019, and the Wuhan Institute of Virology (WIV) in November 2019.

    Many suspect the virus leaked from a lab at the WIV.

    Expert

    Internet 2.0 report not enough to draw conclusions: Expert

    Meanwhile, experts said that the Internet 2.0 report did not provide enough information to draw conclusions on the origins of COVID-19.

    They said PCR testing—which has been in broad use for several decades—has been growing in popularity as it has become a standard method to test for pathogens.

    Experts also argued that PCR is widely used in laboratories to test for many other pathogens.

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Latest
    Coronavirus
    COVID-19
    China

    Latest

    Bangladesh Cricket Board pondering over Bangladesh's tour of Pakistan Bangladesh Cricket Board
    Why Virat Kohli's presence could lift India in England? Stats Virat Kohli
    Google Workspace accounts gain access to Gemini Live feature Google
    Adani Group deploys India's 1st hydrogen-powered truck in Chhattisgarh Adani Group

    Coronavirus

    New C.1.2 variant of COVID-19 found. How dangerous is it? World Health Organization
    Phase 2/3 trials of Corbevax on 5-18 age group permitted COVID-19 Vaccine
    Coronavirus: India reports 47K cases, biggest spike in 2 months Union Health Ministry
    Supreme Court pulls up Centre over compensation for COVID-19 victims Supreme Court Of India

    COVID-19

    UK's decision to not recognize Covishield discriminatory, says India India
    Delhi government happy with HC nod to oxygen deaths probe Delhi High Court
    UK recognizes Covishield, but Indians still need to quarantine S Jaishankar
    COVID-19 vaccines: Sri Lanka seeks $100 million assistance from IMF Pfizer

    China

    Biden expands Trump-era order banning US investment in Chinese firms Donald Trump
    NewsBytes Briefing: Biden goes all Trump on China, and more Google
    NewsBytes Briefing: The internet experienced a brief hiccup, and more Apple
    Death toll in China gas explosion rises to 25 World
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2025